Antidiabetic Constituents from the Dominican Medicinal Plant Momordica charantia
Antidiabetic Constituents from the Dominican Medicinal Plant Momordica charantia
批准号:
7575803
负责人:
Amy Celeste Keller
金额:
$2.67万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2011-02-28
关键词:
AffectAntidiabetic DrugsBiological AssayBlood GlucoseCell LineCellsChemical StructureChronic DiseaseCollectionCommunitiesComplementary and alternative medicineCucurbitaceaeDiabetes MellitusDiagnosisDiseaseDominicanFruitGoalsHerbal MedicineHispanicsHumanHyperglycemiaHypoglycemiaHypoglycemic AgentsIn VitroInsulinInsulin-Dependent Diabetes MellitusInvestigationIslet CellJuiceLeftMeasuresMedicalMedicinal PlantsMedicineMetforminMethodsModelingMomordica charantiaMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusNot Hispanic or LatinoObesityOralPharmaceutical PreparationsPhytochemicalPioglitazonePlantsPlasmaPopulationRattusResearchResearch TechnicsRodent ModelTechniquesTestingTrainingUnited StatesWhole Bloodbasecareercell growthdiabeticfollow-upimprovedin vitro Assayin vitro activityin vitro testingin vivoinsulin secretionmortalitymouse modelskillsstem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Momordica charantia is a widely-used plant in traditional Dominican medicine for diabetes treatment. This project hypothesizes that the active compounds isolated from M. charantia fruits lower blood glucose concentrations via an increase in (3-cell replication and function, resulting in improved insulin secretion. To test this hypothesis, the fruits of M. charantia will be extracted, fractionated, and tested with a p-cell assay in order to identify the active fractions. Various chromatographic methods will be used to isolate the bioactive compounds from the active fractions. After isolation, the active compounds will be identified using modern phytochemical techniques and further tested in vitro using (3-cells to quantify the effects against an established oral hypoglycemic drug as a reference. Two of the bioactive compounds will be selected for in vivo testing based on their activity in the (3-cell line, uniqueness of chemical structure, and yield. The selected compounds will then be tested in a mouse model of obesity-induced hyperglycemia along with positive controls of commonly prescribed medications for Type II diabetes mellitus to functionally investigate the compounds' hypoglycemic activity. In addition, the active compounds isolated from the fruit will be quantified in the stems and leaves of M. charantia, as these parts of the plants are used in traditional Dominican medicine. Many traditional remedies have not been rigorously researched in the scientific and medical communities. Therefore, this project will provide training both in phytochemical techniques and research, and also in the skills necessary for the scientific research of herbal medicine. This interdisciplinary training is vital to a goal of a lifetime career in the rigorous scientific study of complementary and alternative medicine. Momordica charantia is a widely-used plant in treating one of the world's most threatening diseases, diabetes. Although this plant's antidiabetic activity has been researched, very few studies have rigorously tested the bioactive M. charantia compounds for specific mechanisms of action. The results of this study will allow people to make more informed decisions about the use of M. charantia in diabetes treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating Mechanisms of Impaired Vasoreactivity in Thermoneutrality
-
批准号:10701111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Amy Celeste Keller
-
依托单位:
Repair of Vascular Contractility and Mitochondrial Function by NOS Recoupling
-
批准号:9512551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Amy Celeste Keller
-
依托单位:
Repair of Vascular Contractility and Mitochondrial Function by NOS Recoupling
-
批准号:10593038
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Amy Celeste Keller
-
依托单位:
Repair of Vascular Contractility and Mitochondrial Function by NOS Recoupling
-
批准号:10266011
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Amy Celeste Keller
-
依托单位:
Antidiabetic Constituents from the Dominican Medicinal Plant Momordica charantia
-
批准号:7409263
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2008
-
负责人:Amy Celeste Keller
-
依托单位:
海外基金